Metabolic and Cardioprotection By the Myokine Follistatin-like 1 Polypeptide

Described herein are methods and compositions related to the discovery that the Follistatin-like 1 protein (Fstl-1) has metabolic and cardioprotective effects in vivo. Fstl-1 and portions and derivatives or variants thereof can be used to treat or prevent metabolic diseases or disorders and to treat or prevent cardiac damage caused by interrupted cardiac muscle blood supply.

Attached files:


Patents:
WO 2,009,052,478

Inventor(s): WALSH KENNETH [US]; OSHIMA YUICHI [US]; OUCHI NORIYUKI [US]

Type of Offer: Licensing



« More Medical Patents

---